1.8 PLN
5.82 M PLN
110.93 M PLN
About Biogened SA
Sector
Industry
CEO
Andrzej Rafal Grzegorzewski
Website
Headquarters
Lodz
Founded
1949
ISIN
PLBIOGN00018
FIGI
BBG001Z52905
Biogened SA engages in the production and distribution of pharmaceutical products and cosmetics. It operates under the brand name Dermedic. The firm also engages in the research and development in the area of dermatology. The company was founded in 1949 and is headquartered in Lodz, Poland.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BGD is 23.8 PLN — it has decreased by −4.03% in the past 24 hours. Watch Biogened SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NEWCONNECT exchange Biogened SA stocks are traded under the ticker BGD.
BGD stock has fallen by −4.03% compared to the previous week, the month change is a −3.25% fall, over the last year Biogened SA has showed a −15.00% decrease.
BGD stock is 4.20% volatile and has beta coefficient of 0.22. Track Biogened SA stock price on the chart and check out the list of the most volatile stocks — is Biogened SA there?
Yes, you can track Biogened SA financials in yearly and quarterly reports right on TradingView.
BGD net income for the last quarter is 1.43 M PLN, while the quarter before that showed 2.31 M PLN of net income which accounts for −38.16% change. Track more Biogened SA financial stats to get the full picture.
Yes, BGD dividends are paid annually. The last dividend per share was 0.50 PLN. As of today, Dividend Yield (TTM)% is 2.02%. Tracking Biogened SA dividends might help you take more informed decisions.
Biogened SA dividend yield was 4.35% in 2024, and payout ratio reached 42.19%. The year before the numbers were 2.78% and 24.10% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 13, 2025, the company has 222 employees. See our rating of the largest employees — is Biogened SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Biogened SA EBITDA is 12.40 M PLN, and current EBITDA margin is 12.53%. See more stats in Biogened SA financial statements.
Like other stocks, BGD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Biogened SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Biogened SA technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Biogened SA stock shows the buy signal. See more of Biogened SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.